The price of BG Medicine, Inc. (Nasdaq:BGMD) stock skyrocketed $0.24 to $1.39, after the company announced the publication of positive results from VIDAS(R) Galectin-3 study, that demonstrate and validate the analytical and clinical performance of the automated assay, which was developed by one of BG Medicine’s automation partners. BG Medicine, Inc. (NASDAQ:BGMD), stock opened at $1.32 in last session, and closed at $1.39, while the day range of BGMD stock is $1.24 – $1.57. The stock showed a positive weekly performance of 8.59%.
Galena Biopharma Inc (NASDAQ:GALE)’s shares jumped 8.10% to $5.49. Needham & Company on Jan. 21 reiterated a “buy” rating and boosted the target price to $9 from $3.50. Galena Biopharma Inc (NASDAQ:GALE), stock opened at $5.10, in last session and closed at $5.53, by gaining 9.29%. The 52 week range of GALE is $1.65 – $7.77. Company’s market capitalization is $581.96million.
Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), said Tuesday that it has entered into a definitive agreement with certain entities managed by The Baupost Group, L.L.C. for the sale of about 16.4 million shares of its common stock. Idenix Pharmaceuticals, Inc (NASDAQ:IDIX), stock advanced 17.03% and finished the last session at $8.04. The EPS of the stock remained -0.87. Company’s market capitalization is $1.08billion.
Shares of CEL-SCI Corporation (NYSEMKT:CVM) opened at $1.07 and after plunging by 3.74% it closed at $1.03. The intraday range of the stock was $0.88 – $1.08, while its 52-week trading range is of $0.53 and $3.09.CEL-SCI Corporation (NYSEMKT:CVM), stock opened the session at $0.97, and closed the session at $1.09. The 52 week range of the CVM stock remained $0.53 – $3.09 and the day range was $0.91 – $1.10.